Ontera Inc. is a precision diagnostics company aiming to democratize access to molecular information by making it simple, fast and cost-effective at point of need. Leveraging silicon nanopores to sense single molecules in combination with machine learning, Ontera has developed a highly differentiated suite of platforms. In point of care diagnostics, we are developing the only multimodal, highly specific and sensitive MDx platform that can multiplex 20 target proteins, small analytes and NA in less than 20 minutes. In research, we are using our dual pore technology for genome mapping and structural variants while building the only epigenetics tool capable of directly looking at DNA modification, nucleosome phasing and histone modification. Founded in 2011, the company is based in Santa Cruz, California.